In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 5th, 2008 | 37 | Yes |
Popular Name: Imatinib Imatinib
Find On: PubMed — Wikipedia — Google
CAS Numbers: 152459-95-5 , 152459-95-5; 220127-57-1 , 220127-57-1 , [152459-95-5]
152459-95-5; D08066; Glamox (TN); Imatinib (INN)
220127-57-1; D01441; Gleevec (TN); Glivec (TN); Imatinib mesilate (JAN); Imatinib mesylate (USAN)
CHEBI:305376; CHEBI:45781; CHEBI:38918
CPD000469175; IMATINIB MESYLATE
CPD000469175; IMATINIB MESYLATE; SAM001246622
Imatinib Mesylate (FDA); Imatinib (BAN
imatinib mesylate; imatinib methansulfonate; imatinib monomesylate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.89 | 13.15 | -49.4 | 3 | 8 | 1 | 87 | 494.623 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.89 | 13.03 | -52.36 | 3 | 8 | 1 | 87 | 494.623 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.89 | 10.78 | -14.7 | 2 | 8 | 0 | 86 | 493.615 | 7 | ↓ |
Lo Low (pH 4.5-6) | 3.89 | 13.63 | -88.27 | 4 | 8 | 2 | 89 | 495.631 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Antineoplastic agent | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.46e-02 g/l | DrugBank-approved |
UniProt Database Links | ABL1_HUMAN; ABL1_MOUSE; ABL2_HUMAN; ABL2_MOUSE; CSF1R_HUMAN; CSF1R_MOUSE; GSAP_HUMAN; KIT_HUMAN | ChEBI |
UniProt Database Links | ABL1_HUMAN; ABL1_MOUSE; ABL2_HUMAN; ABL2_MOUSE; GSAP_HUMAN; PGFRA_HUMAN; PGFRA_MOUSE; PGFRA_RAT; PGFRB_HUMAN | ChEBI |
Therapy | antineoplastic | SMDC Iconix |
biological_use | Antineoplastic agent | IBScreen Bioactives IBScreen Bioactives |
Patent Database Links | EP1683523; EP1813609; EP1857454; EP1900369; EP1917965; EP1920767; EP1949898; EP1977765; EP1988098; EP1992347; US2005009849; US2005065169; US2005085490; US2005137213; US2005192287; US2005234069; US2005261337; US2005276812; US2006009472; US2006079526; US200 | ChEBI |
Patent Database Links | EP1719527 | ChEBI |
Indications | leukemia, GI tumors | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP000530i; 1 methanesulfonic acid | NIH Clinical Collection via PubChem |
Target | PDGFR, c-Kit, Bcr-Abl | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP000530i; SALT: 1 methanesulfonic acid | NIH Clinical Collection via PubChem |
mechanism | Tyrosine kinase inhibitor | IBScreen Bioactives |
biological_use | Used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
A1Z199-1-E | BCR/ABL P210 Fusion Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 750 | 0.23 | Binding ≤ 10μM |
ABCG2-2-E | ATP-binding Cassette Sub-family G Member 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4898 | 0.20 | Binding ≤ 10μM |
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.30 | Binding ≤ 10μM |
ABL2-1-E | Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.31 | Binding ≤ 10μM |
BCR-1-E | Breakpoint Cluster Region Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 473 | 0.24 | Binding ≤ 10μM |
BLK-1-E | Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 520 | 0.24 | Binding ≤ 10μM |
BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.21 | Binding ≤ 10μM |
CAH1-1-E | Carbonic Anhydrase I (cluster #1 Of 12), Eukaryotic | Eukaryotes | 32 | 0.28 | Binding ≤ 10μM |
CAH12-1-E | Carbonic Anhydrase XII (cluster #1 Of 9), Eukaryotic | Eukaryotes | 980 | 0.23 | Binding ≤ 10μM |
CAH13-2-E | Carbonic Anhydrase XIII (cluster #2 Of 7), Eukaryotic | Eukaryotes | 7450 | 0.19 | Binding ≤ 10μM |
CAH14-8-E | Carbonic Anhydrase XIV (cluster #8 Of 8), Eukaryotic | Eukaryotes | 468 | 0.24 | Binding ≤ 10μM |
CAH15-2-E | Carbonic Anhydrase 15 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 78 | 0.27 | Binding ≤ 10μM |
CAH2-1-E | Carbonic Anhydrase II (cluster #1 Of 15), Eukaryotic | Eukaryotes | 30 | 0.28 | Binding ≤ 10μM |
CAH3-1-E | Carbonic Anhydrase III (cluster #1 Of 6), Eukaryotic | Eukaryotes | 528 | 0.24 | Binding ≤ 10μM |
CAH4-1-E | Carbonic Anhydrase IV (cluster #1 Of 16), Eukaryotic | Eukaryotes | 4553 | 0.20 | Binding ≤ 10μM |
CAH6-1-E | Carbonic Anhydrase VI (cluster #1 Of 8), Eukaryotic | Eukaryotes | 392 | 0.24 | Binding ≤ 10μM |
CAH7-1-E | Carbonic Anhydrase VII (cluster #1 Of 8), Eukaryotic | Eukaryotes | 109 | 0.26 | Binding ≤ 10μM |
CAH9-1-E | Carbonic Anhydrase IX (cluster #1 Of 11), Eukaryotic | Eukaryotes | 76 | 0.27 | Binding ≤ 10μM |
CDK19-1-E | Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5500 | 0.20 | Binding ≤ 10μM |
CLK1-2-E | Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4500 | 0.20 | Binding ≤ 10μM |
CLK4-1-E | Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4200 | 0.20 | Binding ≤ 10μM |
CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 960 | 0.23 | Binding ≤ 10μM |
DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 43 | 0.28 | Binding ≤ 10μM |
DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 15 | 0.30 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 7600 | 0.19 | Binding ≤ 10μM |
EPHA8-1-E | Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.21 | Binding ≤ 10μM |
FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2400 | 0.21 | Binding ≤ 10μM |
FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.21 | Binding ≤ 10μM |
FYN-1-E | Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic | Eukaryotes | 5500 | 0.20 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3600 | 0.21 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 97 | 0.27 | Binding ≤ 10μM |
KSYK-1-E | Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5000 | 0.20 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 62 | 0.27 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 220 | 0.25 | Binding ≤ 10μM |
MELK-1-E | Maternal Embryonic Leucine Zipper Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.22 | Binding ≤ 10μM |
MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 5000 | 0.20 | Binding ≤ 10μM |
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5200 | 0.20 | Binding ≤ 10μM |
MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3300 | 0.21 | Binding ≤ 10μM |
MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2600 | 0.21 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 90 | 0.27 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 72 | 0.27 | Binding ≤ 10μM |
PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.19 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.22 | Binding ≤ 10μM |
ST17A-1-E | Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5300 | 0.20 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4300 | 0.20 | Binding ≤ 10μM |
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 2), Eukaryotic | Eukaryotes | 90 | 0.27 | Functional ≤ 10μM |
BCR-1-E | Breakpoint Cluster Region Protein (cluster #1 Of 2), Eukaryotic | Eukaryotes | 90 | 0.27 | Functional ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.20 | Functional ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 96 | 0.27 | Functional ≤ 10μM |
Z50466-1-O | Trypanosoma Cruzi (cluster #1 Of 8), Other | Other | 9000 | 0.19 | Functional ≤ 10μM |
Z80036-1-O | BaF3 (IL-3-dependent Pro-B-cells) (cluster #1 Of 3), Other | Other | 9100 | 0.19 | Functional ≤ 10μM |
Z80166-4-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other | Other | 60 | 0.27 | Functional ≤ 10μM |
Z80186-1-O | K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other | Other | 6 | 0.31 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 10000 | 0.19 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
A1Z199_HUMAN | A1Z199 | BCR/ABL P210 Fusion Protein, Human | 204 | 0.25 | Binding ≤ 1μM |
BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 1.1 | 0.34 | Binding ≤ 1μM |
CAH15_MOUSE | Q99N23 | Carbonic Anhydrase 15, Mouse | 78 | 0.27 | Binding ≤ 1μM |
CAH1_HUMAN | P00915 | Carbonic Anhydrase I, Human | 31.9 | 0.28 | Binding ≤ 1μM |
CAH2_HUMAN | P00918 | Carbonic Anhydrase II, Human | 30.2 | 0.28 | Binding ≤ 1μM |
CAH3_HUMAN | P07451 | Carbonic Anhydrase III, Human | 528 | 0.24 | Binding ≤ 1μM |
CAH9_HUMAN | Q16790 | Carbonic Anhydrase IX, Human | 75.7 | 0.27 | Binding ≤ 1μM |
CAH6_HUMAN | P23280 | Carbonic Anhydrase VI, Human | 392 | 0.24 | Binding ≤ 1μM |
CAH7_HUMAN | P43166 | Carbonic Anhydrase VII, Human | 109 | 0.26 | Binding ≤ 1μM |
CAH12_HUMAN | O43570 | Carbonic Anhydrase XII, Human | 980 | 0.23 | Binding ≤ 1μM |
CAH14_HUMAN | Q9ULX7 | Carbonic Anhydrase XIV, Human | 468 | 0.24 | Binding ≤ 1μM |
DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 141 | 0.26 | Binding ≤ 1μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.7 | 0.35 | Binding ≤ 1μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 19 | 0.29 | Binding ≤ 1μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 160 | 0.26 | Binding ≤ 1μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 14 | 0.30 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 1000 | 0.23 | Binding ≤ 1μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 100 | 0.26 | Binding ≤ 1μM |
ABL1_MOUSE | P00520 | Tyrosine-protein Kinase ABL, Mouse | 10.8 | 0.30 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 430 | 0.24 | Binding ≤ 1μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 10 | 0.30 | Binding ≤ 1μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 520 | 0.24 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 160 | 0.26 | Binding ≤ 1μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 220 | 0.25 | Binding ≤ 1μM |
ABCG2_HUMAN | Q9UNQ0 | ATP-binding Cassette Sub-family G Member 2, Human | 3380 | 0.21 | Binding ≤ 10μM |
A1Z199_HUMAN | A1Z199 | BCR/ABL P210 Fusion Protein, Human | 204 | 0.25 | Binding ≤ 10μM |
BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 1.1 | 0.34 | Binding ≤ 10μM |
MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 3200 | 0.21 | Binding ≤ 10μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 5200 | 0.20 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 3100 | 0.21 | Binding ≤ 10μM |
CAH15_MOUSE | Q99N23 | Carbonic Anhydrase 15, Mouse | 78 | 0.27 | Binding ≤ 10μM |
CAH1_HUMAN | P00915 | Carbonic Anhydrase I, Human | 31.9 | 0.28 | Binding ≤ 10μM |
CAH2_HUMAN | P00918 | Carbonic Anhydrase II, Human | 30.2 | 0.28 | Binding ≤ 10μM |
CAH3_HUMAN | P07451 | Carbonic Anhydrase III, Human | 528 | 0.24 | Binding ≤ 10μM |
CAH4_HUMAN | P22748 | Carbonic Anhydrase IV, Human | 4553 | 0.20 | Binding ≤ 10μM |
CAH9_HUMAN | Q16790 | Carbonic Anhydrase IX, Human | 75.7 | 0.27 | Binding ≤ 10μM |
CAH6_HUMAN | P23280 | Carbonic Anhydrase VI, Human | 392 | 0.24 | Binding ≤ 10μM |
CAH7_HUMAN | P43166 | Carbonic Anhydrase VII, Human | 109 | 0.26 | Binding ≤ 10μM |
CAH12_HUMAN | O43570 | Carbonic Anhydrase XII, Human | 980 | 0.23 | Binding ≤ 10μM |
CAH13_MOUSE | Q9D6N1 | Carbonic Anhydrase XIII, Mouse | 7450 | 0.19 | Binding ≤ 10μM |
CAH14_HUMAN | Q9ULX7 | Carbonic Anhydrase XIV, Human | 468 | 0.24 | Binding ≤ 10μM |
CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 5500 | 0.20 | Binding ≤ 10μM |
DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 141 | 0.26 | Binding ≤ 10μM |
CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 2100 | 0.21 | Binding ≤ 10μM |
CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 4500 | 0.20 | Binding ≤ 10μM |
EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 1400 | 0.22 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 7600 | 0.19 | Binding ≤ 10μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.7 | 0.35 | Binding ≤ 10μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 1274 | 0.22 | Binding ≤ 10μM |
MELK_HUMAN | Q14680 | Maternal Embryonic Leucine Zipper Kinase, Human | 1900 | 0.22 | Binding ≤ 10μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 2600 | 0.21 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 160 | 0.26 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 14 | 0.30 | Binding ≤ 10μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 2800 | 0.21 | Binding ≤ 10μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 3300 | 0.21 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 1000 | 0.23 | Binding ≤ 10μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 7800 | 0.19 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 1700 | 0.22 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 4300 | 0.20 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 100 | 0.26 | Binding ≤ 10μM |
ABL1_MOUSE | P00520 | Tyrosine-protein Kinase ABL, Mouse | 10.8 | 0.30 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 430 | 0.24 | Binding ≤ 10μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 10 | 0.30 | Binding ≤ 10μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 520 | 0.24 | Binding ≤ 10μM |
FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 2400 | 0.21 | Binding ≤ 10μM |
FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 1500 | 0.22 | Binding ≤ 10μM |
FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 3100 | 0.21 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 160 | 0.26 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 220 | 0.25 | Binding ≤ 10μM |
KSYK_HUMAN | P43405 | Tyrosine-protein Kinase SYK, Human | 5000 | 0.20 | Binding ≤ 10μM |
Z80036 | Z80036 | BaF3 (IL-3-dependent Pro-B-cells) | 400 | 0.24 | Functional ≤ 10μM |
BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 90 | 0.27 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 10000 | 0.19 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 60 | 0.27 | Functional ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 90 | 0.27 | Functional ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 96 | 0.27 | Functional ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 219 | 0.25 | Functional ≤ 10μM |
Z50466 | Z50466 | Trypanosoma Cruzi | 9000 | 0.19 | Functional ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 90 | 0.27 | Functional ≤ 10μM |
Description | Species |
---|---|
Abacavir transmembrane transport | |
Activation of BIM and translocation to mitochondria | |
Activation of BMF and translocation to mitochondria | |
Activation of the AP-1 family of transcription factors | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
ARMS-mediated activation | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
DCC mediated attractive signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
Erythrocytes take up carbon dioxide and release oxygen | |
Erythrocytes take up oxygen and release carbon dioxide | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Frs2-mediated activation | |
GAB1 signalosome | |
Generation of second messenger molecules | |
Golgi Associated Vesicle Biogenesis | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Growth hormone receptor signaling | |
Integrin alphaIIb beta3 signaling | |
Interleukin-2 signaling | |
Iron uptake and transport | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MEK activation | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Nephrin interactions | |
Netrin mediated repulsion signals | |
Non-integrin membrane-ECM interactions | |
NRAGE signals death through JNK | |
NRIF signals cell death from the nucleus | |
Oxidative Stress Induced Senescence | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
Platelet sensitization by LDL | |
PLCG1 events in ERBB2 signaling | |
PPARA activates gene expression | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of gene expression by Hypoxia-inducible Factor | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Reversible hydration of carbon dioxide | |
Rho GTPase cycle | |
Role of Abl in Robo-Slit signaling | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
Sema3A PAK dependent Axon repulsion | |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR1 fusion mutants | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
Signalling to p38 via RIT and RIN | |
Spry regulation of FGF signaling | |
Stimuli-sensing channels | |
Transcriptional regulation of white adipocyte differentiation | |
Translocation of ZAP-70 to Immunological synapse | |
VEGFA-VEGFR2 Pathway |